thereafter, the respondent developed severe toxic epidermal necrolysis. As a result, she is severely disfigured, physically disabled and almost blind (Mutual Pharmaceutical Co., Inc. v. Bartlett, 2013). In 2005, the respondent sued the petitioner in New Hampshire state court shortly after the FDA recommended a warning label change on NSAIDs to indicate toxic epidermal necrolysis as a possible side effect. The petitioner, Mutual Pharmaceutical, had the case removed to federal court based on the supremacy…
Words 1688 - Pages 7